\u798f\u6cf0\u5236\u836f\uff08Vertex Pharmaceuticals, NASDAQ: VRTX\uff09<\/a>\u4e0eHCA Healthcare\uff08NYSE: HCA\uff09\u3002<\/p>\n\u798f\u6cf0\u5236\u836f\uff1aCF\u6cbb\u7597\u9886\u57df\u7684\u5784\u65ad\u8005<\/h2>\n
\u8fd9\u5bb6\u751f\u7269\u6280\u672f\u516c\u53f8\u4ee5\u56ca\u6027\u7ea4\u7ef4\u5316\uff08CF\uff09\u521b\u65b0\u7597\u6cd5\u95fb\u540d\u4e8e\u4e16\u3002\u8be5\u75be\u75c5\u4f1a\u5bfc\u81f4\u60a3\u8005\u4f53\u5185\u7c98\u6db2\u5f02\u5e38\u589e\u539a\uff0c\u5f15\u53d1\u591a\u5668\u5b98\u635f\u4f24\u3002\u798f\u6cf0\u5236\u836f\u4e0d\u65ad\u63a8\u8fdb\u836f\u7269\u8fed\u4ee3\uff0c\u800c\u4e14\u5168\u7403\u90fd\u6ca1\u6709\u7ade\u4e89\u5bf9\u624b\uff0c\u5728CF\u6cbb\u7597\u9886\u57df\u5360\u636e\u7edd\u5bf9\u4e3b\u5bfc\u5730\u4f4d\u3002\u56ca\u6027\u7ea4\u7ef4\u5316\u9700\u8981\u6301\u7eed\u6cbb\u7597\uff0c\u56e0\u6b64\u5373\u4fbf\u7ecf\u6d4e\u4f4e\u8ff7\uff0c\u60a3\u8005\u4ecd\u5c06\u4f9d\u8d56\u8fd9\u4e9b\u6551\u547d\u836f\u7269\u3002<\/p>\n
\u798f\u6cf0\u5236\u836f\u8d22\u52a1\u4e1a\u7ee9\u5f3a\u52b2\uff0c2024\u5e74\u6536\u5165\u540c\u6bd4\u589e\u957f12%\u81f3110.2\u4ebf\u7f8e\u5143\u3002<\/p>\n
\u516c\u53f8\u6838\u5fc3\u4ea7\u54c1\u6301\u7eed\u653e\u91cf\u4e4b\u4f59\uff0c\u7ba1\u7ebf\u548c\u4ea7\u54c1\u7ebf\u62d3\u5c55\u4e5f\u6210\u6548\u663e\u8457\uff1a\u975e\u963f\u7247\u7c7b\u6025\u6027\u6b62\u75db\u836fJournavx\uff0c\u4ee5\u53ca\u6cbb\u7597\u7f55\u89c1\u8840\u6db2\u75be\u75c5\u7684Casgevy\u5df2\u83b7\u6279\u4e0a\u5e02\uff0c\u9488\u5bf9APOL-1\u4ecb\u5bfc\u80be\u75c5\u7684\u4e09\u671f\u4e34\u5e8a\u836f\u7269inaxaplin\u66f4\u53ef\u80fd\u586b\u8865\u5e02\u573a\u7a7a\u767d\u3002\u51ed\u501f\u73b0\u6709\u5784\u65ad\u4f18\u52bf\u53e0\u52a0\u4e30\u5bcc\u7684\u7814\u53d1\u7ba1\u7ebf\uff0c\u798f\u6cf0\u5236\u836f\u5177\u5907\u7a7f\u8d8a\u7ecf\u6d4e\u5468\u671f\u7684\u5f3a\u5927\u97e7\u6027\u3002<\/p>\n
HCA Healthcare\uff1a\u533b\u7597\u521a\u9700\u6784\u7b51\u62a4\u57ce\u6cb3<\/h2>\n
\u4f5c\u4e3a\u5168\u7f8e\u6700\u5927\u8fde\u9501\u533b\u9662\u4e4b\u4e00\uff0cHCA\u62e5\u6709\u8d85\u8fc7\u767e\u5bb6\u533b\u7597\u8bbe\u65bd\u3002\u5c3d\u7ba1\u7ecf\u6d4e\u8870\u9000\u53ef\u80fd\u5f71\u54cd\u90e8\u5206\u975e\u5fc5\u8981\u8bca\u7597\u9879\u76ee\uff0c\u4f46\u6025\u8bca\u7b49\u521a\u6027\u9700\u6c42\u4ecd\u5c06\u652f\u6491\u516c\u53f8\u7684\u57fa\u672c\u9762\u3002\u8fc7\u53bb\u4e94\u5e74\uff0c\u8be5\u96c6\u56e2\u6210\u529f\u514b\u670d\u75ab\u60c5\u51b2\u51fb\u3001\u901a\u80c0\u538b\u529b\u4e0e\u81ea\u7136\u707e\u5bb3\u7b49\u591a\u91cd\u6311\u6218\uff0c\u6301\u7eed\u6269\u5927\u5e02\u573a\u4efd\u989d\u2014\u2014\u5e02\u5360\u7387\u4ece2012\u5e74\u768424%\u7a33\u6b65\u63d0\u5347\u81f32022\u5e74\u768427%\uff0c\u5e76\u8ba1\u5212\u57282030\u5e74\u8fbe\u523029%\u3002<\/p>\n
\u901a\u8fc7\u6301\u7eed\u6295\u8d44\u70ed\u95e8\u533b\u7597\u670d\u52a1\uff0c\u4e0e\u533b\u60a3\u4ee5\u53ca\u652f\u4ed8\u65b9\u7684\u957f\u671f\u5173\u7cfb\uff0c\u4ee5\u53ca\u5b8c\u5584\u7684\u5168\u56fd\u7f51\u7edc\u5e03\u5c40\uff0cHCA\u5c55\u73b0\u51fa\u8d85\u8d8a\u540c\u4e1a\u7684\u6297\u98ce\u9669\u80fd\u529b\u3002\u5bf9\u4e8e\u5fe7\u8651\u7ecf\u6d4e\u524d\u666f\u7684\u6295\u8d44\u8005\uff0c\u4e43\u81f3\u957f\u671f\u4ef7\u503c\u6295\u8d44\u8005\uff0c\u8fd9\u90fd\u582a\u79f0\u4f18\u8d28\u7684\u914d\u7f6e\u9009\u62e9\u3002<\/p>\n
\u5c0f\u7ed3<\/h2>\n
\u4e24\u5bb6\u4f01\u4e1a\u5171\u540c\u7279\u70b9\u5728\u4e8e\uff1a\u4f9d\u6258\u533b\u7597\u521a\u9700\u6784\u5efa\u5546\u4e1a\u62a4\u57ce\u6cb3\uff0c\u901a\u8fc7\u5dee\u5f02\u5316\u4f18\u52bf\u7ef4\u6301\u6301\u7eed\u589e\u957f\u3002\u65e0\u8bba\u7ecf\u6d4e\u5468\u671f\u5982\u4f55\u6ce2\u52a8\uff0c\u8fd9\u7c7b\u4f01\u4e1a\u59cb\u7ec8\u503c\u5f97\u957f\u671f\u5173\u6ce8\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
\u7279\u6717\u666e\u653f\u5e9c\u7684\u8d38\u6613\u653f\u7b56\u6301\u7eed\u52a0\u5267\u5e02\u573a\u5bf9\u4e8e\u7ecf\u6d4e\u8870\u9000\u7684\u62c5\u5fe7\u60c5\u7eea\uff0c\u867d\u7136\u5f53\u524d\u5f62\u52bf\u5c1a\u672a\u5b8c\u5168\u6076\u5316\uff0c\u4f46\u672a\u96e8\u7ef8\u7f2a\u59cb\u7ec8\u662f\u660e\u667a\u9009\u62e9\u3002\u82e5 […]<\/p>\n","protected":false},"author":27,"featured_media":560394,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[820,455,925,1859],"class_list":["post-571156","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-820","tag-455","tag-925","tag-1859","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/571156","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=571156"}],"version-history":[{"count":1,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/571156\/revisions"}],"predecessor-version":[{"id":571162,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/571156\/revisions\/571162"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/560394"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=571156"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=571156"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=571156"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}